Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.5 (
urease
)
7,257
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Background
. There are several diagnostic methods for
Helicobacter pylori (H. pylori)
infection. A cost-effective analysis is needed to decide on the optimal diagnostic method. The aim of this study was to determine a cost-effective diagnostic method in patients with atrophic gastritis (AG).
Methods
. A decision-analysis model including seven diagnostic methods was constructed for patients with AG diagnosed by esophagogastroduodenoscopy. Expected values of cost and effectiveness were calculated for each test.
Results
. If the prevalence of
H. pylori
in the patients with AG is 85% and
CAM
-resistant
H. pylori
is 30%, histology, stool
H. pylori
antigen (SHPAg), bacterial culture (BC), and urine
H. pylori
antibody (UHPAb) were dominated by serum
H. pylori
IgG antibody (SHPAb), rapid
urease
test (RUT), and urea breath test (UBT). Among three undominated methods, the incremental cost-effective ratios (ICER) of RUT versus SHPAb and UBT versus RUT were $214 and $1914, respectively. If the prevalence of
CAM
-sensitive
H. pylori
was less than 55%, BC was not dominated, but its
H. pylori
eradication success rate was 0.86.
Conclusions
. RUT was the most cost-effective at the current prevalence of
CAM
-resistant
H. pylori
. BC could not be selected due to its poor effectiveness even if
CAM
-resistant
H. pylori
was more than 45%.
...
PMID:Cost-Effectiveness Analysis of
Helicobacter pylori
Diagnostic Methods in Patients with Atrophic Gastritis. 2833 17